338 related articles for article (PubMed ID: 24436123)
1. Structural analysis of protein-ligand interactions: the binding of endogenous compounds and of synthetic drugs.
Gallina AM; Bork P; Bordo D
J Mol Recognit; 2014 Feb; 27(2):65-72. PubMed ID: 24436123
[TBL] [Abstract][Full Text] [Related]
2. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
3. Aromatic interactions at atom-to-atom contact and just beyond: a case study of protein interactions of NAD⁺/NADP⁺.
Gupta P; Durani S
Int J Biol Macromol; 2011 Dec; 49(5):999-1006. PubMed ID: 21903128
[TBL] [Abstract][Full Text] [Related]
4. PLI: a web-based tool for the comparison of protein-ligand interactions observed on PDB structures.
Gallina AM; Bisignano P; Bergamino M; Bordo D
Bioinformatics; 2013 Feb; 29(3):395-7. PubMed ID: 23196990
[TBL] [Abstract][Full Text] [Related]
5. Molecular determinants for ATP-binding in proteins: a data mining and quantum chemical analysis.
Mao L; Wang Y; Liu Y; Hu X
J Mol Biol; 2004 Feb; 336(3):787-807. PubMed ID: 15095988
[TBL] [Abstract][Full Text] [Related]
6. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
[TBL] [Abstract][Full Text] [Related]
7. Geometry of nonbonded interactions involving planar groups in proteins.
Chakrabarti P; Bhattacharyya R
Prog Biophys Mol Biol; 2007; 95(1-3):83-137. PubMed ID: 17629549
[TBL] [Abstract][Full Text] [Related]
8. Side-chain flexibility in proteins upon ligand binding.
Najmanovich R; Kuttner J; Sobolev V; Edelman M
Proteins; 2000 May; 39(3):261-8. PubMed ID: 10737948
[TBL] [Abstract][Full Text] [Related]
9. Chemical fragments that hydrogen bond to Asp, Glu, Arg, and His side chains in protein binding sites.
Chan AW; Laskowski RA; Selwood DL
J Med Chem; 2010 Apr; 53(8):3086-94. PubMed ID: 20230000
[TBL] [Abstract][Full Text] [Related]
10. The occurrence of C--H...O hydrogen bonds in alpha-helices and helix termini in globular proteins.
Manikandan K; Ramakumar S
Proteins; 2004 Sep; 56(4):768-81. PubMed ID: 15281129
[TBL] [Abstract][Full Text] [Related]
11. N-H...O, O-H...O, and C-H...O hydrogen bonds in protein-ligand complexes: strong and weak interactions in molecular recognition.
Sarkhel S; Desiraju GR
Proteins; 2004 Feb; 54(2):247-59. PubMed ID: 14696187
[TBL] [Abstract][Full Text] [Related]
12. Drug-like density: a method of quantifying the "bindability" of a protein target based on a very large set of pockets and drug-like ligands from the Protein Data Bank.
Sheridan RP; Maiorov VN; Holloway MK; Cornell WD; Gao YD
J Chem Inf Model; 2010 Nov; 50(11):2029-40. PubMed ID: 20977231
[TBL] [Abstract][Full Text] [Related]
13. Propensities of polar and aromatic amino acids in noncanonical interactions: nonbonded contacts analysis of protein-ligand complexes in crystal structures.
Imai YN; Inoue Y; Yamamoto Y
J Med Chem; 2007 Mar; 50(6):1189-96. PubMed ID: 17315854
[TBL] [Abstract][Full Text] [Related]
14. PDB-Ligand: a ligand database based on PDB for the automated and customized classification of ligand-binding structures.
Shin JM; Cho DH
Nucleic Acids Res; 2005 Jan; 33(Database issue):D238-41. PubMed ID: 15608186
[TBL] [Abstract][Full Text] [Related]
15. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
Bhunia SS; Roy KK; Saxena AK
J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
[TBL] [Abstract][Full Text] [Related]
16. Halogen interactions in protein-ligand complexes: implications of halogen bonding for rational drug design.
Sirimulla S; Bailey JB; Vegesna R; Narayan M
J Chem Inf Model; 2013 Nov; 53(11):2781-91. PubMed ID: 24134121
[TBL] [Abstract][Full Text] [Related]
17. How different are structurally flexible and rigid binding sites? Sequence and structural features discriminating proteins that do and do not undergo conformational change upon ligand binding.
Gunasekaran K; Nussinov R
J Mol Biol; 2007 Jan; 365(1):257-73. PubMed ID: 17059826
[TBL] [Abstract][Full Text] [Related]
18. Statistical analysis of atomic contacts at RNA-protein interfaces.
Treger M; Westhof E
J Mol Recognit; 2001; 14(4):199-214. PubMed ID: 11500966
[TBL] [Abstract][Full Text] [Related]
19. Halogenated ligands and their interactions with amino acids: implications for structure-activity and structure-toxicity relationships.
Kortagere S; Ekins S; Welsh WJ
J Mol Graph Model; 2008 Sep; 27(2):170-7. PubMed ID: 18524655
[TBL] [Abstract][Full Text] [Related]
20. Strong and weak hydrogen bonds in protein-ligand complexes of kinases: a comparative study.
Panigrahi SK
Amino Acids; 2008 May; 34(4):617-33. PubMed ID: 18180869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
